STAT3 and diabetic kidney disease: Besides, the regulation of PKM2 modulates inflammation by phosphorylating STAT3 and NF-κB in DKD that delays the differentiation of macrophages to M1 cells, and the downregulation of phosphorylated PKM2 is beneficial for DKD treatment (Li et al., 2020).